Conference Coverage

ERAS reduced opioid use, improved same-day discharge after gyn surgery

View on the News

Monitor for unintended ERAS consequences

The ERAS pathway described by Dr. Carter-Brooks embraces the core tenets of enhanced recovery, including standardized patient education, multimodal analgesia, and predefined postoperative metrics, according to invited discussant Mark Walters, MD.

Dr. Mark Walters

Dr. Mark Walters

“They documented reduced patient stays and excellent patient satisfaction when they introduced these deliberate and systematic performance improvement practices,” he said. “But implementing these protocols doesn’t happen in a vacuum.”

In fact, systematic culture change requires the involvement of surgeons, nurses, anesthesiologists, and administrative staff, Dr. Walters added.

“Additionally, such significant behavioral changes inevitably result in unintended consequences that must be carefully documented to learn how to mitigate harm in future patients,” he said.

Dr. Walters is professor and vice chair of gynecology in the Center of Urogynecology and Reconstructive Pelvic Surgery, department of obstetrics and gynecology at the Cleveland Clinic. He is a consultant and teacher for Coloplast.


 

REPORTING FROM SGS 2018


Eligible patients included those undergoing benign or oncologic gynecologic surgery with a planned overnight stay.

“Preliminary positive outcomes have been found [with ERAS] at our urban safety-net hospital, specifically in looking at decreased opioid use without a resultant total adverse event increase. It is important for us to continue to monitor ERAS in terms of long-term care to ensure adherence, safety, and effectiveness,” she said, adding that tracking of outcomes will continue, and a future goal is to assess impacts on cost.

Dr. Carter-Brooks’s study was supported by a National Institutes of Health grant. She and Ms. Fowler each reported having no disclosures.

SOURCES: Carter-Brooks C et al.; Fowler M et al. SGS 2018, Oral presentation 2; Oral posters 1 and 16.

Pages

Recommended Reading

Survey: Litigation fears drive response to FDA power morcellator warnings
MDedge Family Medicine
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
MDedge Family Medicine
FDA updates breast implant–associated lymphoma cases, risk
MDedge Family Medicine
Same-day discharge for hysterectomy
MDedge Family Medicine
Sling revisions: pain as indication linked with SUI recurrence
MDedge Family Medicine
Study: No increased risk of serious AEs with combined urogyn/gyn onc surgery
MDedge Family Medicine
Fast-track catheter management offers little benefit after benign hysterectomy
MDedge Family Medicine
Life and health are not even across the U.S.
MDedge Family Medicine
Complication rates rise after decline in uterine fibroid morcellation
MDedge Family Medicine
Study: Preop EKGs have little utility for benign hysterectomy
MDedge Family Medicine